Three-way approach for precision strike against pancreatic cancer
Cancer Pancreatic Cancer T Cell

Three-way approach for precision strike against pancreatic cancer

Alejandro Noval
Alejandro Noval

London researchers have developed a three-pronged strategy to tackle pancreatic cancer by combining a drug and viruses that target cancer cells with immune cells from the patients, modified to specifically attack pancreatic cancer cells.

In 10 seconds? Scientists have reported positive preliminary results in lab mice with pancreatic cancer using a combination of a drug, genetically engineered viruses and immune cells.

Get unlimited access to our 3-min Digests and other premium features

Choose your plan:

Personal

$99/year

✅ Includes 7-day free trial for new users
✅ Weekly Recap
✅ Daily newsletter
✅ Access 4 topic areas of your choosing
✅ Access all citations and resources
✅ Gain background knowledge with a Quick Dive
✅ The Sparrow Sessions Podcast
✅ No ads
❌ Direct access to the Expert Network
❌ Your questions - answered by an Expert Scientist
❌ 12 hours of consultations with our fabulous experts per year (that’s 1 hour per month!)
❌ Access to all topic areas as we scale the Content Library

We'll send you a reminder email 3 days before your trial ends.

Start my free trial

Professional

$3499/year

✅ Includes 7-day free trial for new users
✅ Weekly Recap
✅ Daily newsletter
✅ Access all citations and resources
✅ Gain background knowledge with a Quick Dive
✅ The Sparrow Sessions Podcast
✅ No ads
✅ Direct access to the Expert Network
✅ Your questions - answered by an Expert Scientist
✅ 12 hours of consultations with our fabulous experts per year (that’s 1 hour per month!)
✅ Access to all topic areas as we scale the Content Library

We'll send you a reminder email 3 days before your trial ends.

Start my free trial